Biostatistics and Data Management Section

生物统计和数据管理科

• 批准号: 6558385
• 负责人: SETH M STEINBERG
• 金额: --
• 依托单位: DIVISION OF CLINICAL SCIENCES - NCI
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/6558385
• 关键词: AIDS therapy; HIV infections; cancer information system; cancer registry /resource; clinical trials; computer data analysis; data management; diagnosis design /evaluation; drug screening /evaluation; experimental designs; human data; method development; neoplasm /cancer classification /staging; neoplasm /cancer therapy; prognosis; statistical service /center; statistics /biometry

The Section is the statistical and data management component of the Center for Cancer Research (CCR). The Section provides statistical leadership and data management consultation for major activities of the Center, and is involved in the design, conduct, monitoring, and statistical analyses of intramural and national multicenter clinical trials of experimental treatments for cancer, and intramural clinical trials for treatment of AIDS. Other major collaborative efforts include studies to identify important prognostic and treatment selection factors, evaluate diagnostic procedures, develop improved staging systems, and assist investigators in the design, execution, and analyses of major in vitro drug testing studies. The Section develops and implements new statistical designs and biometric methods related to the development and evaluation of new cancer and AIDS treatments. The Section maintains computerized data collection systems for intramural and national multicenter clinical protocols, and it works closely with interested branches to improve data recording and retrieval. The Section maintains a unified system for tracking basic information on all patients registered on CCR treatment protocols. Approximately 15% of the Section's activities are HIV-AIDS related.

该科是癌症研究中心的统计和数据管理部门。该科为中心的主要活动提供统计领导和数据管理咨询，并参与设计、实施、监测和统计分析校内和国家多中心癌症实验性治疗临床试验，以及校内艾滋病治疗临床试验。其他主要的合作努力包括研究，以确定重要的预后和治疗选择因素，评估诊断程序，开发改进的分期系统，并协助研究人员在设计，执行和分析的主要体外药物试验研究。该科制定和实施与开发和评价新的癌症和艾滋病治疗方法有关的新的统计设计和生物鉴别方法。该科为校内和国家多中心临床协议维持计算机化数据收集系统，并与有关部门密切合作，改进数据记录和检索。该科维持一个统一的系统，用于跟踪在CCR治疗方案中登记的所有病人的基本信息。该科大约15%的活动与艾滋病毒/艾滋病有关。